WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 2'5501 Infant (under 12 months) mortality rate: 332
GDP / capita (US$): 6'1301 Child (under 5 years) mortality rate: 412

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 10'671  10'496  10'324  10'157  9'993  8'495  6'794  5'369 
Births 275  273  271  270  268  267  250  213 
Surviving infants 264  262  260  258  257  251  229  187 
Pop. less than 5 years 1'279  1'264  1'258  1'261  1'262  1'218  1'063  869 
Pop. less than 15 years 3'720  3'695  3'674  3'661  3'646  3'382  2'786  2'288 
Female 15-49 years 2'712  2'660  2'608  2'554  2'503  2'056  1'635  1'263 

Number of reported case

(Click for retrospective incidence data for Bolivia (Plurinational State of))
Diphtheria 31 
Japanese encephalitis
Measles 122  820  4'181 
Mumps 764  1'096  1'781  3'696  680 
Pertussis 31  10  159  2'377 
Polio* 48 
Rubella 434 
Rubella (CRS)
Tetanus (neonatal) 46 
Tetanus (total) 46  153 
Yellow fever 50  46 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Bolivia (Plurinational State of))
Vaccine year result method % card seen                                                
BCG 2012  100  EPI     85  87  90  90  88  95  48  30 
DTP1 2006  97  DHS   77  86  85  90  87  87  98 
DTP3 2012  93  EPI     80  80  82  80  85  89  41  11 
HepB_BD         
HepB3 2012  93  EPI     81  80  82  80  85  89 
Hib3 2012  93  EPI     81  80  82  80  85  89 
JapEnc         
MCV 2012  90  EPI     83  84  84  79  86  100  53  13 
MCV2         
PCV1         
PCV3         
Pol3 2012  93  EPI     80  79  82  80  84  89  50  14 
Rota1          81  80  85  83  80 
Rota_last          77  76  80  76  65 
Rubella1          83  84  84  79  86 
TT2plus 1999  54  MICS   54  26  27  76  51 
PAB         
VAD1          50  47  49  48  47  19 
YFV 2012  86  EPI     80  82  81  63  61  12 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Bolivia (Plurinational State of))
BCG 99  99  99  98  94  92  65  30 
DTP1 98  97  98  97  97  92  66  32 
DTP3 94  93  95  91  93  75  41  11 
HepB3 94  93  95  91  93  77 
HepB_BD
Hib3 94  93  95  91  93  77 
MCV 95  96  96  88  93  84  53  13 
MCV2
PAB 76  76  74  74  74  67  23 
PCV3
Pol3 95  93  95  90  92  74  50  14 
Rota_last 93  91  91  87  76 
YFV 91  93  92  74  72 

Number of districts in the country 337  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 26
From 80 to 89% 15
From 50 to 79% 42
Less than 50% 17
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHep 2, 4, 6, 18 months; 4 years; Yes
Influenza 6-24 months; >= 65 years; Yes
MMR 12-23 months; Yes
OPV 2, 4, 6, 18 months; 4 years; Yes
Rotavirus 2, 4 months; Yes
Td 1st contact; +1, +6 months; +1, +1 year; Yes
VitaminA 6-11, 12-59 months; Yes
YF 12-23 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2010-2015    2010-2015  2007-2011     
Nº of districts with microplans that include activities to raise immunization coverage number 105  105  105  105  105    327 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  No  No       

System performance

Total Nº districts in country number 337  337  337  337  327  327  327 
Nº districts with DTP3 coverage >=80% number 139  137  159  154  161  174  54 
% of districts with DTP3 coverage >=80% From 0 to 100% 41  41  47  46  49  53  17 
Nº districts with measles (MCV1) coverage >=95% number 86  106  95  79  100  91   
% of districts with MCV1 coverage >=95% From 0 to 100% 26  31  28  23  31  28   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  75  100    100  100  100 

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.